State Street Corp Vir Biotechnology, Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, State Street Corp holds 5,625,533 shares of VIR stock, worth $45.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,625,533
Previous 5,094,888 10.42%
Holding current value
$45.8 Million
Previous $45.3 Million 7.08%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$7.26 - $10.7 $3.85 Million - $5.68 Million
530,645 Added 10.42%
5,625,533 $42.1 Million
Q2 2024

Aug 14, 2024
SELL
$7.63 - $12.66 $15.1 Million - $25 Million
-1,972,733 Reduced 27.91%
5,094,888 $45.3 Million
Q1 2024

May 15, 2024
BUY
$8.6 - $11.9 $1.34 Million - $1.85 Million
155,539 Added 2.25%
7,067,621 $71.6 Million
Q4 2023

Feb 14, 2024
SELL
$7.76 - $10.29 $2.03 Million - $2.69 Million
-261,346 Reduced 3.64%
6,912,082 $69.5 Million
Q3 2023

Nov 14, 2023
BUY
$9.14 - $24.62 $16 Million - $43.2 Million
1,754,624 Added 32.38%
7,173,428 $67.2 Million
Q2 2023

Aug 14, 2023
BUY
$23.2 - $27.29 $803,671 - $945,352
34,641 Added 0.64%
5,418,804 $133 Million
Q1 2023

May 15, 2023
SELL
$22.26 - $30.85 $2.05 Million - $2.85 Million
-92,294 Reduced 1.69%
5,384,163 $125 Million
Q4 2022

Feb 14, 2023
SELL
$19.96 - $28.22 $7.07 Million - $9.99 Million
-353,960 Reduced 6.07%
5,476,457 $139 Million
Q3 2022

Nov 15, 2022
BUY
$18.26 - $31.1 $5.68 Million - $9.68 Million
311,279 Added 5.64%
5,830,417 $112 Million
Q2 2022

Aug 15, 2022
BUY
$19.08 - $26.7 $25.3 Million - $35.4 Million
1,325,374 Added 31.6%
5,519,138 $141 Million
Q1 2022

May 16, 2022
BUY
$21.19 - $40.01 $35.3 Million - $66.6 Million
1,665,657 Added 65.89%
4,193,764 $108 Million
Q4 2021

Feb 14, 2022
BUY
$30.97 - $54.03 $7.44 Million - $13 Million
240,241 Added 10.5%
2,528,107 $106 Million
Q3 2021

Nov 15, 2021
BUY
$34.9 - $54.54 $4.74 Million - $7.41 Million
135,931 Added 6.32%
2,287,866 $99.6 Million
Q2 2021

Aug 16, 2021
BUY
$38.75 - $51.0 $10.6 Million - $13.9 Million
273,208 Added 14.54%
2,151,935 $102 Million
Q1 2021

May 17, 2021
SELL
$26.34 - $83.07 $27.8 Million - $87.8 Million
-1,056,977 Reduced 36.0%
1,878,727 $96.3 Million
Q4 2020

Feb 16, 2021
BUY
$25.51 - $43.38 $51.2 Million - $87.1 Million
2,006,874 Added 216.06%
2,935,704 $78.6 Million
Q3 2020

Nov 10, 2020
BUY
$28.28 - $53.6 $2.64 Million - $5.01 Million
93,486 Added 11.19%
928,830 $31.9 Million
Q2 2020

Aug 14, 2020
BUY
$27.89 - $47.86 $19.8 Million - $33.9 Million
708,966 Added 560.99%
835,344 $34.2 Million
Q1 2020

May 11, 2020
BUY
$12.04 - $60.2 $1.52 Million - $7.61 Million
126,378 New
126,378 $4.33 Million

Others Institutions Holding VIR

# of Institutions
219
Shares Held
87.4M
Call Options Held
127K
Put Options Held
1.19M
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $1.08B
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email